cardiovascular

Red heart sewn into white fabric

Biotech

Kardigan itching for IPO to fund late-stage cardio pipeline

Kardigan may have only launched last year, but it seems the cardiovascular-focused biotech is already eyeing the public markets.

James Waldron May 27, 2026 4:57am

Stop sign and red lights at traffic intersection

Genentech shreds RIPK1 inhibitor after ph. 2 failure

Mar 19, 2026 2:48pm

Lilly buys inflammation biotech Ventyx for $1.2B

Jan 8, 2026 7:01am

graphic of a larger shark chomping up a smaller one

Cardiometabolic field drives M&A while cancer deals drop: report

Oct 27, 2025 2:39pm

Three knit hearts

Kardigan fashions $254M series B for late-stage pipeline

Oct 14, 2025 9:00am

Stethoscope and red heart with pink background

US VC launches another biotech with China-licensed asset

Sep 17, 2025 10:30am